Could a gut makeover help Alzheimer's? first safety trial begins

NCT ID NCT07332260

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study is testing whether a fecal microbiota transplant (FMT) is safe and feasible for people with mild-to-moderate Alzheimer's disease. Ten participants will receive the transplant via colonoscopy, and researchers will monitor side effects, recruitment rates, and changes in gut bacteria. The goal is to see if this approach is worth studying further for easing Alzheimer's symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital of North Norway, Tromsø

    RECRUITING

    Tromsø, Troms, 9016, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.